Representative problems, anonymised.
These examples describe the nature of the strategic questions and approaches I have worked on. They intentionally avoid confidential client information, proprietary work products and non-public data.
Five-year growth strategy for a global renal-care business
A five-year growth strategy spanning core dialysis technologies, adjacent critical-care opportunities and the commercial capabilities required to convert market potential into growth.
Government and key-account growth for a global MedTech company
A commercial acceleration programme focused on prioritising states, institutions and cross-business opportunities, and improving the operating cadence needed to convert public-sector opportunities into growth.
Commercial diligence of a healthcare-financing and health-tech platform
Investor-side commercial diligence of a differentiated health platform, assessing market attractiveness, business-model quality, customer economics, competitive differentiation and scalability.
Commercial diligence of an ambulatory-care platform
Commercial diligence of an asset-light ambulatory-care model, testing procedure migration, site economics, physician and hospital relationships, city expansion and the repeatability of growth.
MedTech market entry and acquisition screening
Assessment of attractive MedTech categories, entry pathways and potential acquisition targets for a technology-led strategic entrant evaluating participation in the Indian market.
Partner strategy for an integrated preventive-health ecosystem
Evaluation and prioritisation of strategic partners for a large-scale preventive-health ecosystem, focusing on clinical capability, operating fit, scalability and the role each partner could play in an integrated model.